BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dessels C, Alessandrini M, Pepper MS. Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape. Stem Cells Transl Med. 2018;7:643-650. [PMID: 29777574 DOI: 10.1002/sctm.17-0244] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Sun Z, Yao B, Xie H, Su X. Clinical Progress and Preclinical Insights Into Umbilical Cord Blood Transplantation Improvement. Stem Cells Transl Med 2022:szac056. [PMID: 35972332 DOI: 10.1093/stcltm/szac056] [Reference Citation Analysis]
2 Hendricks CL, Naidoo A, Thejpal R, Rapiti N, Neethling B, Goga Y, Buldeo S. Childhood aplastic anaemia with paroxysmal nocturnal haemoglobinuria clones: A retrospective single-centre study in South Africa. Afr J Lab Med 2022;11. [DOI: 10.4102/ajlm.v11i1.1537] [Reference Citation Analysis]
3 Mansoorabadi Z, Kheirandish M. The upregulation of Gata transcription factors family and FOG-1 in expanded and differentiated cord blood-derived CD34+ hematopoietic stem cells to megakaryocyte lineage during co-culture with cord blood mesenchymal stem cells. Transfus Apher Sci 2022;:103481. [PMID: 35690555 DOI: 10.1016/j.transci.2022.103481] [Reference Citation Analysis]
4 Lonergan B, Williams RA, Matsushige T, Machin LL. Exploring “quality” in cord blood transfusion: uncertainties, bionetworks, and collaborations. New Genetics and Society. [DOI: 10.1080/14636778.2022.2077183] [Reference Citation Analysis]
5 Abbaszadeh H, Ghorbani F, Derakhshani M, Abbasi B, Jalili Z, Talebi M, Yousefi M, Shamsasenjan K, Edalati M, Hakimi P, Sanei M, Yaghoubi R, Movassaghpour AA. The effect of Acellularized Wharton's Jelly-derived exosomes on myeloid differentiation of umbilical cord blood-derived CD34+ hematopoietic stem cells. Gene Reports 2021;25:101298. [DOI: 10.1016/j.genrep.2021.101298] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Querol S, Rubinstein P, Madrigal A. The wider perspective: cord blood banks and their future prospects. Br J Haematol 2021. [PMID: 33877692 DOI: 10.1111/bjh.17468] [Reference Citation Analysis]
7 Viljoen IM, Hendricks CL, Mellet J, Pepper MS. Perspectives on establishing a public cord blood inventory in South Africa. Cytotherapy 2021;23:548-57. [PMID: 33836979 DOI: 10.1016/j.jcyt.2021.02.116] [Reference Citation Analysis]
8 Vairy S, Louis I, Vachon MF, Richer J, Teira P, Cellot S, Villeneuve E, Haddad E, Duval M, Bittencourt H. Intrabone infusion for allogeneic umbilical cord blood transplantation in children. Bone Marrow Transplant 2021;56:1937-43. [PMID: 33824433 DOI: 10.1038/s41409-021-01275-0] [Reference Citation Analysis]
9 Akil AA, Yassin E, Al-Maraghi A, Aliyev E, Al-Malki K, Fakhro KA. Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era. J Transl Med 2021;19:137. [PMID: 33794915 DOI: 10.1186/s12967-021-02778-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Adigbli G, Hua P, Uchiyama M, Roberts I, Hester J, Watt SM, Issa F. Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis In Vivo. Front Immunol 2021;12:642198. [PMID: 33868276 DOI: 10.3389/fimmu.2021.642198] [Reference Citation Analysis]
11 Siddesh SE, Gowda DM, Jain R, Gulati A, Patil GS, Anudeep TC, Jeyaraman N, Muthu S, Jeyaraman M. Placenta-derived mesenchymal stem cells (P-MSCs) for COVID-19 pneumonia-a regenerative dogma. Stem Cell Investig 2021;8:3. [PMID: 33688491 DOI: 10.21037/sci-2020-034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
12 Islami M, Soleimanifar F. A Review of Evaluating Hematopoietic Stem Cells Derived from Umbilical Cord Blood's Expansion and Homing. Curr Stem Cell Res Ther 2020;15:250-62. [PMID: 31976846 DOI: 10.2174/1574888X15666200124115444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Um S, Ha J, Choi SJ, Oh W, Jin HJ. Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells. World J Stem Cells 2020; 12(12): 1511-1528 [PMID: 33505598 DOI: 10.4252/wjsc.v12.i12.1511] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
14 Min K, Suh MR, Cho KH, Park W, Kang MS, Jang SJ, Kim SH, Rhie S, Choi JI, Kim HJ, Cha KY, Kim M. Potentiation of cord blood cell therapy with erythropoietin for children with CP: a 2 × 2 factorial randomized placebo-controlled trial. Stem Cell Res Ther 2020;11:509. [PMID: 33246489 DOI: 10.1186/s13287-020-02020-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Qiu H, Qian T, Wu T, Wang X, Zhu C, Chen C, Wang L. Umbilical cord blood cells for the treatment of preterm white matter injury: Potential effects and treatment options. J Neurosci Res 2021;99:778-92. [PMID: 33207392 DOI: 10.1002/jnr.24751] [Reference Citation Analysis]
16 Gupta AO, Wagner JE. Umbilical Cord Blood Transplants: Current Status and Evolving Therapies. Front Pediatr 2020;8:570282. [PMID: 33123504 DOI: 10.3389/fped.2020.570282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Golchin A, Farahany TZ. Biological Products: Cellular Therapy and FDA Approved Products. Stem Cell Rev Rep. 2019;15:166-175. [PMID: 30623359 DOI: 10.1007/s12015-018-9866-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 25.0] [Reference Citation Analysis]
18 Page A, Fusil F, Cosset FL. Towards Physiologically and Tightly Regulated Vectored Antibody Therapies. Cancers (Basel) 2020;12:E962. [PMID: 32295072 DOI: 10.3390/cancers12040962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Konuma T, Kanda J, Inamoto Y, Hayashi H, Kobayashi S, Uchida N, Sugio Y, Tanaka M, Kobayashi H, Kouzai Y, Takahashi S, Eto T, Mukae J, Matsuhashi Y, Fukuda T, Takanashi M, Kanda Y, Atsuta Y, Kimura F. Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017. Am J Hematol 2020;95:343-53. [PMID: 31849102 DOI: 10.1002/ajh.25705] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
20 Alatyyat SM, Alasmari HM, Aleid OA, Abdel-Maksoud MS, Elsherbiny N. Umbilical cord stem cells: Background, processing and applications. Tissue Cell 2020;65:101351. [PMID: 32746993 DOI: 10.1016/j.tice.2020.101351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
21 Casteleiro Costa P, Ledwig P, Bergquist A, Kurtzberg J, Robles FE. Noninvasive white blood cell quantification in umbilical cord blood collection bags with quantitative oblique back-illumination microscopy. Transfusion 2020;60:588-97. [PMID: 32056228 DOI: 10.1111/trf.15704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 Xue E, Milano F. Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies. F1000Res 2020;9:F1000 Faculty Rev-26. [PMID: 31984133 DOI: 10.12688/f1000research.20605.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Botein EF, Darwish A, El-Tantawy NL, El-Baz R, Eid MI, Shaltot AM. Serological and molecular screening of umbilical cord blood for Toxoplasma gondii infection. Transpl Infect Dis 2019;21:e13117. [PMID: 31102567 DOI: 10.1111/tid.13117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Park M, Koh H, Lee YH. Repurposing the public cord blood bank inventory in Korea to enhance cord blood use. Transfus Apher Sci 2019;58:332-6. [PMID: 31053332 DOI: 10.1016/j.transci.2019.03.020] [Reference Citation Analysis]
25 Brown KS, Rao MS, Brown HL. The Future State of Newborn Stem Cell Banking. J Clin Med 2019;8:E117. [PMID: 30669334 DOI: 10.3390/jcm8010117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]